Effect of binge cocaine treatment on hindlimb vascular function

Journal of Applied Toxicology

Volumn 25, Issue 6, 2005, Pages 479-490

  Pradhan, Leena ^a   Dabisch, Paul A ^b   Liles, John T ^a   Murthy, S N ^a   Baber, Syed R ^a   Simpson, Scott A ^a   Agrawal, Krishna C ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b EDGEWOOD CHEMICAL BIOLOGICAL CENTER   (United States)

Author keywords

Acetylcholine; Adrenergic; Binge; Cocaine; Endothelin; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ADRENERGIC RECEPTOR; COCAINE; ENDOTHELIN; ISOPRENALINE; NITRATE; NITRIC OXIDE; NITRITE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; CHRONIC TOXICITY; COCAINE DEPENDENCE; CONTROLLED STUDY; HINDLIMB; ILIAC ARTERY; LIMB BLOOD VESSEL; MALE; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE;

ACETYLCHOLINE; ANIMALS; BRADYKININ; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HINDLIMB; MALE; NITROPRUSSIDE; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; TIME FACTORS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

ANIMALIA;

EID: 29944443817     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.1083     Document Type: Article

References (68)

1. Ambre JJ, Connelly TJ, Ruo T, Henthorn TK. 1991. Acute tolerance to the chronotropic effect of cocaine in humans. In Cardiovascular Toxicity of Cocaine: Underlying Mechanisms, Thadani P (ed.). NIDA Research Monographs 108: 41-54.
2. Avakian EV, LeRoy M, St. John AK, Sayre FW, Malone MH. 1990. Effects of chronic cocaine in isolated perfused rat hearts. Life Sci. 46: 1569-1574.
3. Bacharach JM, Colville DS, Lie JT. 1992. Accelerated atherosclerosis, aneurysmal disease, and aortitis: possible pathogenetic association with cocaine abuse. Int. Angiol. 11: 83-86.
4. Bachetti T, Comini L, Agnoletti L, Pedersini P, Gaia G, Cargnoni A, Bellet M, Curello S, Ferrari R. 1998. Effects of chronic noradrenaline on the nitric oxide pathway in human endothelial cells. Basic Res. Cardiol. 93: 250-256.
5. Benzaquen BS, Cohen V, Eisenberg MJ. 2001. Effects of cocaine on the coronary arteries. Am. Heart J. 142: 402-410.
6. Beveridge TJ, Smith HR, Nader MA, Porrino LJ. 2004. Functional effects of cocaine self-administration in primate brain regions regulating cardiovascular function. Neurosci. Lett. 370: 201-205.
7. Chang SL, Bersig J, Felix B, Fiala M, House SD. 2000. Chronic cocaine alters hemodynamics and leukocyte-endothelial interactions in rat mesenteric venules. Life Sci. 66: 2357-2369.
8. Clancy RM, Abramson SB. 2000. Acetylcholine prevents intercellular adhesion molecule 1 (CD54)-induced focal adhesion complex assembly in endothelial cells via a nitric oxide-cGMP-dependent pathway. Arthritis Rheum. 43: 2260-2264.
9. Copeland JR, Willoughby KA, Police RJ, Ellis EF. 1996. Repeated cocaine administration reduces bradykinin-induced dilation of pial arterioles. Am. J. Physiol. 271: H1576-H1583.
10. Dabisch PA, Kerut EK, Liles JT, Wien G, Smith M, Patterson M, McCoul ED, Sears BW, Saenz R, Kadowitz PJ. 2004b. Responses to bradykinin are mediated by NO-independent mechanisms in the rat hindlimb vascular bed. Pharmacol. Res. 50: 575-584.
11. + channels in the NO-independent vasodilator response to acetylcholine. Pharmacol. Res. 49: 207-215.
12. DAWN Report: Drug Abuse Warning Network October 2002. Available from http://www.samhsa.gov/oas/majorDAWN.pdf.
13. Dressler FA, Malekzadeh S, Roberts WC. 1990. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am. J. Cardiol. 65: 303-308.
14. D'Souza FM, Sparks RL, Chen H, Kadowitz PJ, Jeter JR Jr. 2003. Mechanism of eNOS gene transfer inhibition of vascular smooth muscle cell proliferation. Am. J. Physiol. Cell Physiol. 284: C191-C199.
15. Fandino J, Sherman JD, Zuccarello M, Rapoport RM. 2003. Cocaine-induced endothelin-1-dependent spasm in rabbit basilar artery in vivo. J. Cardiovasc. Pharmacol. 41: 158-161.
16. Feitelson JB, Kulenovic E, Beck DJ, Harris PD, Passmore JC, Malkani AL, Fleming JT. 2002. Endogenous norepinephrine regulates blood flow to the intact rat tibia. J. Orthopaed. Res. 20: 391-396.
17. Fischman MW, Schuster CR. 1982. Cocaine self-administration in humans. Fed. Proc. 41: 241-246.
18. Fischman MW, Schuster CR, Javaid J, Hatano Y, Davis J. 1985. Acute tolerance development to the cardiovascular and subjective effects of cocaine. J. Pharmacol. Exp. Ther. 235: 677-682.
19. Fogo A, Superdock KR, Atkinson JB. 1992. Severe arteriosclerosis in the kidney of a cocaine addict. Am. J. Kidney Dis. 20: 513-515.
20. Foltin RW, Fischman MW. 1991. Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J. Pharmacol. Exp. Ther. 257: 247-261.
21. Foltin RW, Fischman MW, Pedroso JJ, Pearlson GD. 1988. Repeated intranasal cocaine administration: lack of tolerance to pressor effects. Drug Alcohol Depend. 22: 169-177.
22. Gan X, Zhang L, Berger O, Stins MF, Way D, Taub DD, Chang SL, Kim KS, House SD, Weinand M, Witte M, Graves MC, Fiala M. 1999. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin. Immunol. 91: 68-76.
23. Gattullo D, Pagliaro P, Marsh NA, Losano G. 1999. New insights into nitric oxide and coronary circulation. Life Sci. 65: 2167-2174.
24. Gillis RA, Hernandez YM, Erzouki HK, Rackowski FC, Mandal AK, Kuhn FE, Dretchen KL. 1995. Sympathetic nervous system mediated cardiovascular effects of cocaine are primarily due to a peripheral site of action of the drugs. Drug Alcohol Depend. 37: 217-230.
25. Havranek EP, Nademanee K, Grayburn PA, Eichhorn EJ. 1996. Endothelium-dependent vasorelaxation is impaired in cocaine arteriopathy. J. Am. Coll. Cardiol. 28: 1168-1174.
26. He J, Xiao Y, Casiano CA, Zhang L. 2000a. Role of mitochondrial cytochrome c in cocaine-induced apoptosis in coronary artery endothelial cells. J. Pharmacol. Exp. Ther. 295: 896-903.
27. He J, Xiao Y, Zhang L. 2000b. Cocaine induces apoptosis in human coronary artery endothelial cells. J. Cardiovasc. Pharmacol. 35: 572-580.
28. He J, Xiao Y, Zhang L. 2001. Cocaine-mediated apoptosis in bovine coronary artery endothelial cells: role of nitric oxide. J. Pharmacol. Exp. Ther. 298: 180-187.
29. Jones LF, Tackett RL. 1990. Chronic cocaine treatment enhances the responsiveness of the left anterior descending coronary artery and the femoral artery to vasoactive substances. J. Pharmacol. Exp. Ther. 225: 1366-1370.
30. Katz JL, Griffiths JW, Sharpe LG, de Souza EB, Witkin JM. 1992. Cocaine tolerance and cross tolerance. J. Pharmacol. Exp. Ther. 264: 183-192.
31. Kolodgie FD, Virmani R, Cornhill JF, Herderick EE, Smialek J. 1991. Increase in atherosclerosis adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J. Am. Coll. Cardiol. 17: 1553-1560.
32. Kolodgie FD, Wilson PS, Mergner WJ, Virmani R. 1999. Cocaine-induced increase in the permeability function of human vascular endothelial cell monolayers. Exp. Mol. Pathol. 66: 109-122.
33. Kumor K, Sherer M, Thompson L, Cone E, Mahaffey J, Jaffe JH. 1988. Lack of cardiovascular tolerance during intravenous cocaine infusions in human volunteers. Life Sci. 42: 2063-2071.
34. Lange RA, Hillis LD 2001. Cardiovascular complications of cocaine use. N. Engl. J. Med. 345: 351-358.
35. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. 1995. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 92: 2426-2431.
36. Mathew V, Hasdai D, Lerman A. 1996. The role of endothelin in coronary atherosclerosis. Mayo Clinic Proc. 71: 769-777.
37. Mathier MA, Shen YT, Shannon RP. 2002. Exaggerated cardiovascular effects of cocaine in conscious dogs with pacing-induced dilated cardiomyopathy. J. Card. Fail. 8: 407-415.
38. Matsuzki M, Springier PJ, Misra AL, Mule SJ. 1976. Cocaine: tolerance to its convulsant and cardiorespiratory stimulating effects in the monkey. Life Sci. 19: 193-203.
39. Mawji IA, Marsden PA. 2003. Perturbations in paracrine control of the circulation: role of the endothelial-derived vasomediators, endothelin-1 and nitric oxide. Microsc. Res. Tech. 60: 46-58.
40. McGuire JJ, Ding H, Triggle CR. 2001. Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s). Can. J. Physiol. Pharmacol. 79: 443-470.
41. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. 1992. Plasma endothelin in chronic heart failure. Circulation 85: 1374-1379.
42. Mehta MC, Jain AC, Billie MD. 2001. Combined effects of cocaine and nicotine on cardiovascular performance in a canine model. Clin. Cardiol. 24: 620-626.
43. Mehta MC, Jain AC, Billie M. 2004. Effects of cocaine and caffeine alone and in combination on cardiovascular performance: an experimental hemodynamic and coronary flow reserve study in a canine model. Int. J. Cardiol. 97: 225-232.
44. Mellion BT, Ignarro LJ, Myers CB, Ohlstein EH, Ballot BA, Hyman AL, Kadowitz PJ. 1983. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol. Pharmacol. 23: 653-664.
45. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ. 1981. Evidence for the inhibitory role of guanosine 3′,5′- monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946-955.
46. Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Margolick JB, Lai S. 2003. Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users. Int. J. Cardiol. 88: 191-198.
47. Mo W, Singh AK, Arruda JA, Dunea G. 1998. Role of nitric oxide in cocaine-induced acute hypertension. Am. J. Hypertens. 11: 708-714.
48. Morgan D, Roberts DC. 2004. Sensitization to the reinforcing effects of cocaine following binge-abstinent self-administration. Neurosci. Biohehav. Rev. 27: 803-812.
49. Mouhaffel AH, Madu EC, Satmary WA, Fraker TD Jr. 1995. Cardiovascular complications of cocaine. Chest 107: 1426-1434.
50. Mukherjee C, Caorn MG, Lefkowtiz RJ 1976. Regulation of adenylate cyclase coupled beta-adrenergic receptors by beta-adrenergic catecholamines. Endocrinology 99: 347-357.
51. Murad F. 1997. What are the molecular mechanisms for the antiproliferative effects of nitric oxide and cGMP in vascular smooth muscle? [comment]. Circulation 95: 1101-1103.
52. Nossaman BD, Kaye AD, Feng CJ, Kang B, Kadowitz PJ. 1997. Analysis of responses to bradykinin in the rat hindquarters vascular bed. Am. J. Physiol. 272: R631-R639.
53. Nunez BD, Miao L, Klein MA, Nunez MM, Travers KE, Ross JN, Carrozza JP Jr, Morgan JP. 1997. Acute and chronic cocaine exposure can produce myocardial ischemia and infarction in Yucatan swine. J. Cardiovasc. Pharmacol. 29: 145-155.
54. Pacher R, Stanek B, Hulsmann M, Koller-Strametz J, Berger R, Schuller M, Hartter E, Ogris E, Frey B, Heinz G, Maurer G. 1996. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J. Am. Coll. Cardiol. 27: 633-641.
55. Parkington HC, Chow JA, Evans RG, Coleman HA, Tare M. 2002. Role for endothelium-derived hyperpolarizing factor in vascular tone in rat mesenteric and hindlimb circulations in vivo. J. Physiol. 542: 929-937.
56. Pradhan L, Dabisch PA, Liles JT, Agrawal KC, Kadowitz PJ. 2003. Effect of acute intravenous cocaine administration on endothelium-dependent vasodepressor responses to acetylcholine. J. Cardiovasc. Pharmacol. Ther. 8: 43-51.
57. Qian H, Neplioueva V, Shetty GA, Channon KM, George SE. 1999. Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. [comment]. Circulation 99: 2979-2982.
58. Resnick RB, Kestenbaum RS, Schwartz LK. 1977. Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes. Science 195: 696-698.
59. Ross R. 1990. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801.
60. Rossi GP, Seccia TM, Nussdorfer GG. 2001. Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. Int. Rev. Cytol. 209: 241-272.
61. Schindler CW, Zheng JW, Goldberg SR. 2001. Effects of cocaine and cocaine metabolites on cardiovascular function in squirrel monkeys. Eur. J. Pharmacol. 431: 53-59.
62. Shannon RP, Lozano P, Cai Q, Manders TW, Shen Y. 1996. Mechanism of the systemic, left ventricular and coronary vascular tolerance to a binge of cocaine in conscious dogs. Circulation 94: 534-541.
63. Tarizzo V, Rubio MC. 1985. Effects of cocaine on several adrenergic system parameters. Gen. Pharmacol. 16: 71-74.
64. Trouve R, Nahas CG, Maner WM. 1991. Catecholamines, cocaine toxicity, and their antidotes in the rat. Proc. Soc. Exp. Biol. Med. 196: 184-192.
65. Vecchione RE, Vazquez J, Bermudez M, Negrin D, Antequera R. 2002. Cocaine long-term administration induces myocardial depressant effects and adrenoceptors desensitization. Acta Cient. Venez. 53: 225-231.
66. Wilbert-Lampen U, Seliger C, Zilker T, Arendt RM. 1998. Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: reversal by coincubation with sigma-receptor antagonists. Circulation 98: 385-390.
67. Williams JB, Keenan SM, Gan Q, Knuepfer MM. 2003. Hemodynamic response profile predicts susceptibility to cocaine-induced toxicity. Eur. J. Pharmacol. 464: 189-196.
68. Zhao M, Hagler HK, Muntz KH. 1996. Regulation of alpha 1-, beta 1-, and beta 2-adrenergic receptors in rat heart by norepinephrine. Am. J. Physiol. 271: H1762-H1768.